Exploration of Novel 3-Substituted Azetidine Derivatives As Triple Reuptake Inhibitors

Journal of Medicinal Chemistry
2012.0

Abstract

Novel azetidines based on the 3-aryl-3-oxypropylamine scaffold were designed, synthesized, and evaluated as TRIs. Reduction of 1 followed by Swern oxidation and then Grignard reaction gave 3. The alkylation of 3 provided the corresponding azetidine derivatives 6, of which the two most promising, 6bd and 6be, were selected from 86 prepared analogues based on their biological profiles. Compound 6be showed activity in vivo in FST at 10 mg/kg IV or 20-40 mg/kg PO.

Knowledge Graph

Similar Paper

Exploration of Novel 3-Substituted Azetidine Derivatives As Triple Reuptake Inhibitors
Journal of Medicinal Chemistry 2012.0
Exploration of 3-Aminoazetidines as Triple Reuptake Inhibitors by Bioisosteric Modification of 3-α-Oxyazetidine
ACS Medicinal Chemistry Letters 2014.0
Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors
Bioorganic & Medicinal Chemistry Letters 2014.0
1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors
Journal of Medicinal Chemistry 2010.0
Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors
European Journal of Medicinal Chemistry 2014.0
6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor
Journal of Medicinal Chemistry 2010.0
Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis and serotonin receptor activity of the arylpiperazine alkyl/propoxy derivatives of new azatricycloundecanes
European Journal of Medicinal Chemistry 2009.0
Design, synthesis, and biological evaluation of novel 4-oxobenzo[d]1,2,3-triazin-benzylpyridinum derivatives as potent anti-Alzheimer agents
Bioorganic & Medicinal Chemistry 2019.0
Azetidine derivatives as novel γ-aminobutyric acid uptake inhibitors: Synthesis, biological evaluation, and structure–activity relationship
European Journal of Medicinal Chemistry 2010.0